INTRODUCTION AND OBJECTIVES: Active surveillance (AS)
is a valid option for patients with small renal masses and in particular in the setting of benign neoplasms such as oncocytoma. We compared functional outcomes of partial nephrectomy (PN) and active surveillance (AS) in patients with oncocytoma.
METHODS: Two-center (UC San Diego, Spectrum Health) retrospective analysis of patients with oncocytoma managed with PN or AS. All patients who underwent AS for oncocytoma underwent confirmatory renal mass biopsy beforehand. Primary outcome was development of de novo chronic kidney disease (CKD) stage 3 [estimated glomerular filtration rate<60 ml/min/1.73m2 (eGFR<60)]. Secondary outcome was change in eGFR between diagnosis and last follow up. Multivariable analysis (MVA) was carried out for potential factors associated with development of de-novo CKD at last follow-up. Figure) . Linear regression analysis demonstrated active surveillance (estimate 0.022; p[0.05) as being associated with increasing DeGFR.
CONCLUSIONS: AS was associated with greater functional decline than PN in oncocytomas. Growth of an untreated neoplasm could have a negative impact on renal function via replacement of parenchyma, paraneoplastic effects of secreted factors, or physiologic effects on the nearby kidney. Our findings support consideration of PN to optimize renal functional preservation in oncocytoma when appropriate.
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Stephanie Hanchuk, Alp Tuna Beksac, Kennedy Okhawere*, Amr E. Elbakry, Bheesham Dayal, New York, NY; Ronney Abaza, Columbus, OH; Daniel Eun, New York, NY; Akshay Bhandari, Miami, FL; Ashok Hemal, Winston-Salem, NC; James Porter, Seattle, WA; Ketan Badani, New York, NY INTRODUCTION AND OBJECTIVES: Partial nephrectomy (PN) for T1b and T2a tumors has not been established as the reference standard treatment due to unclear functional benefit at the expense of increased surgical complexity and rate of complications. We sought to compare the outcomes of PN and radical nephrectomy (RN) in this cohort of patients.
METHODS: We compared the perioperative, functional, and oncological outcome of PN and RN patients among cT1b (451 PN vs. 156 RN) and cT2a stages (46 PN vs. 78 RN). Specifically, perioperative outcomes, renal functional outcome at discharge and up to 24 months, recurrence, and overall survival were compared. Multivariable regression models were used to compare outcome adjusting for factors associated with PN and RN for the outcome analyzed.
RESULTS: For cT1b renal masses, RN was associated with a 66 minute reduction in operative time (p<.001), 61% reduction in blood loss (p<.001) and a 64% reduction in surgical complications (p[.011); but was also associated with 13.3 times higher odds of acute kidney injury at discharge (p<.001) and greater eGFR decline up to 24 months (p<.001). For cT2a renal masses, RN was associated with a 100 minute reduction in operative time (p<.001) and a 62% reduction in blood loss (p<.001); but was also associated with a 4.2 times higher odds of acute kidney injury at discharge (p[.029). No differences in length of stay, recurrence free survival or overall survival were observed at median follow-up 11.5 months (p>.05 for all).
CONCLUSIONS: PN for cT1b and cT2a tumors is a complex procedure resulting in an increased rate of bleeding and complications compared to RN. However, the functional outcome benefit was
